Gene Therapy Solutions
Gene therapies are transforming medicine, and creating single claims of $2M to $4M that destabilize a group’s year. BCS offers stop loss, reinsurance, and cost containment solutions that help health plans and self-funded employers finance and manage gene therapy risk.
What Is Gene Therapy Insurance?
Gene therapy insurance protects health plans and self-funded employers from the financial impact of high-cost gene and cell therapy claims. Because a single FDA-approved gene therapy can cost $2 million to $4 million, one claim can exceed an employer’s entire expected annual spend. Gene therapy insurance products — including gene-therapy-specific stop loss and reinsurance — cap that exposure, making it possible to offer employees access to life-changing treatments without taking on unpredictable catastrophic risk.
The need is growing fast. More than 40 gene therapies have already been approved globally, and more than 2,100 gene therapies are currently in development, including several nearing regulatory approval.
Typical cost per gene therapy treatment
Gene therapies approved globally
Gene therapies in development
Can exceed a plan’s annual expected spend
Gene Therapy Risk Solutions from BCS
Three complementary ways to finance and manage gene therapy exposure, for payers and employers of every size.
Gene Therapy Reinsurance
For health plans. A reinsurance pool product that covers gene therapy ingredient costs, protecting plans against large, catastrophic claims — with back-end management services included.
Gene Therapy Stop Loss GT
For self-funded employers. Gene-therapy-only stop loss coverage. Stop Loss GT is a standalone product for jumbo groups (generally 3,000+ lives).
Gene Therapy Stop Loss GTS
For self-funded employers. Gene-therapy-only stop loss coverage. Stop Loss GTS sits alongside a traditional stop loss policy as a carve-out for groups of 101+ employees.
Who We Serve
| Audience | Fit |
|---|---|
| Health Plans | Reinsurance pooling for gene therapy ingredient costs, plus back-end management services to protect against catastrophic claims volatility. |
| Large / Jumbo Employers (3,000+ lives) | Stop Loss GT — standalone gene therapy protection, including employers who don’t purchase traditional stop loss but want coverage against the frequency of $2M–$4M treatments. |
| Small-to-Mid-Sized Employers (101+ lives) | Stop Loss GTS — a carve-out that works alongside an existing traditional stop loss policy, covering gene therapy ingredient costs only. |
| Brokers & Consultants | Quoting support and product guidance to help clients close the gene therapy gap in their risk programs. Rates available for upcoming plan. |
How It Works
1. Assess your exposure
Tell us about your population, current stop loss program, and risk tolerance.
2. Get a tailored quote
Options are available for named therapies and pipeline therapies covered upon FDA approval.
3. Protect your plan
Cap gene therapy exposure so you can offer employees access to life-saving treatments with predictable costs.
Why BCS Financial
- Decades of specialty insurance experience serving Blue Cross and Blue Shield plans and beyond.
- Expertise in forward-thinking risk solutions, since the 1908s with the first Organ and Bone Marrow Transplant Pool
- Products underwritten by BCS Insurance Company and 4 Ever Life Insurance Company
- Integrated cost containment partnerships, not just risk transfer
Gene Therapy Insurance FAQs
Gene therapy is a technique that uses genes to treat, prevent, or cure a disease or medical disorder — often by adding new copies of a broken gene or replacing a defective or missing gene with a healthy version.
Traditional stop loss caps an employer’s overall high-cost claims. Stop Loss GT and GTS cover gene therapy costs only — either as a standalone policy (GT, for jumbo groups) or as a carve-out alongside an existing stop loss policy (GTS, for groups of 101+).
Stop Loss GT generally covers employers above 3,000 employee lives. Stop Loss GTS covers groups of 101 or more employees with a traditional stop loss policy in force.
Both products cover named therapies. Depending on the option selected, coverage can include specific pipeline therapies, covered upon FDA approval.
It’s a reinsurance pool that covers gene therapy ingredient costs, protecting health plans against large, catastrophic claims and including back-end management services.
Manage Gene Therapy Risk Before the Next Claim
Talk with a BCS specialist about reinsurance, Stop Loss GT/GTS, and cost containment options for your organization.
Gene Therapy Insights & Resources
